Regulus Therapeutics Inc. Annual Income Tax Expense (Benefit) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Regulus Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
  • Regulus Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Regulus Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $1K, unchanged from 2022.
  • Regulus Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $1K, unchanged from 2021.
  • Regulus Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $1K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1K $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $1K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $1K +$1K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $0 -$1K -100% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $1K -$61K -98.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $62K +$259K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$197K -$193K -4825% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 -$4K +$14K +77.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 -$18K -$19K -1900% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $1K +$24K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 -$23K -$13K -130% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 -$10K -$216K -105% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-19
2011 $206K +$236K Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 -$30K Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.